Novel Therapy in Urothelial Carcinoma: An Evolving Treatment Landscape

Closing out their discussion on urothelial carcinoma, key opinion leaders share clinical pearls and excitement for the evolving treatment landscape.

Related Keywords

,Urothelial Carcinomas ,Urothelial Carcinoma ,Bladder Cancer ,Urothelial Cancer ,Novel Therapy ,Combination Therapy ,Checkpoint Inhibitors ,Targeted Therapy ,Enfortumab Vedotin ,Pembrolizumab ,Avelumab ,Neoadjuvant Therapy ,Neoadjuvant Treatment ,Adjuvant Therapy ,Adjuvant Treatment ,Checkmate 274 ,Imvigor010 ,Ambassador Trial ,Ctdna ,Circulating Tumor Dna ,Nivolumab ,Durvalumab ,